Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 1, 2004, Pages 205-208

  López Muñoz, Francisco ^a   Alamo, Cecilio ^a   Rubio, Gabriel ^b   Cuenca, Eduardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Chlorpromazine; History of psychiatry; Psychopharmacology; Schizophrenia

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTHELMINTIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; BARBITURIC ACID DERIVATIVE; CENTRAL DEPRESSANT AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DYE; MORPHINE DERIVATIVE; NEUROLEPTIC AGENT; PETHIDINE; PHENOTHIAZINE DERIVATIVE; PROMETHAZINE; RESERPINE; THIOPENTAL;

ANESTHESIA; AUTONOMIC NERVOUS SYSTEM; CLINICAL PRACTICE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; DRUG USE; ELECTROCONVULSIVE THERAPY; FRANCE; HISTORY; HUMAN; HYPNOSIS; INDUCED HYPOTHERMIA; MALARIA; MEDICAL RESEARCH; MEDICINE; MENTAL PATIENT; MONOTHERAPY; NEUROLEPTANESTHESIA; OUTPATIENT DEPARTMENT; PREOPERATIVE PERIOD; PSYCHOPHARMACOLOGY; PSYCHOSIS; REM SLEEP; REVIEW; SHOCK; STRESS; SURGEON; TIME;

EID: 0345734354     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00165-9     Document Type: Review

References (24)

1. Caldwell, A.E., 1970. History of psychopharmacology. In: Clark, W.G., Del Giudice, J. (Eds.), Principles of Psychopharmacology. Academic Press, New York, pp. 9-30.
2. Courvoisier, S., Fournel, J., Ducrot, R., Kolsky, M., Koetschet, P., 1953. Propiérties pharmacodynamiques du chlorhydrate de chloro-3 (dimethypamine 3,propyl)-10 phenotiazine (4560RP). Arch. Int. Pharmacodyn. Ther. 92, 305-361.
3. Delay, J., Deniker, P., 1952a. 38 cas de psychoses traitèes par la cure prolongèe et continué de 4560RP. C.R. 50 Congr. Méd. Alién. Neurol. (France) 50, 503-513.
4. Delay, J., Deniker, P., 1952b. Le traitments des psychoses par une méthode neurolytique dérivée de l'hibernothérapie (le 4560 RP utilisé seul en cure prolongée et continue. C.R. 50 Congr. Méd. Alién. Neurol. (France) 50, 495-502.
5. te de deméthylaminopropyl-N-chlorophénothiazine. C.R. 50 Congr. Méd. Alién. Neurol. (France) 50, 514-518.
6. Delay, J., Deniker, P., Harl, J.M., 1952a. Utilisation en thérapeutique d'une phenotiazine d'action centrale selective (4560 RP). Ann. Med. Psychol. 110, 112-117.
7. Delay, J., Deniker, P., Harl, J.M., 1952b. Traitment des états déxcitation et dágitacion par une méthode médicamenteuse dérivée de l'hibernothérapie. Ann. Med. Psychol. 110, 267-273.
8. te de demé thylaminopropyl-N-chloro-phénothiazine (4560 RP). Ann. Med. Psychol. 110, 112-117.
9. Deniker, P., 1989. From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics). Psychiatr. J. Univ. Ott. 14, 253-259.
10. Ginestet, D., 1991. Les neuroleptiques. Développement et situation actuelle. L'Encephale XVII, 149-152.
11. Hamon, J., Paraire, J., Velluz, J., 1952. Remarques sur l'action du 4560RP sur lágitation maniaque. Ann. Med. Psychol. 110, 332-335.
12. Huguet, F., 1991. Les professeurs de la Faculté de Médecine de Paris. Dictionnaire Biographique 1794-1939. Institut National de recherche Pédagogique, Paris, pp. 366-369.
13. Jarvik, M.E., 1970. Drugs used in the treatment of psychiatric disorders. In: Goodman, L.S., Gilman, A. (Eds.), The Pharmacological Basis of Therapeutics, 4th ed. Macmillan, New York, pp. 151-203.
14. Laborit, H., Huguenard, P., 1951. L'hibernation artifielle par moyens pharmacodynamiques of physiques. Presse Med. 59, 1329.
15. Laborit, H., Huguenard, P., Alluaume, R., 1952a. Un nouveau stabilisateur végétatif (le 4560 RP). Presse Med. 60, 206-208.
16. Laborit, H., Jaulmes, C., Bénitte, A., 1952b. Certain experimental aspects of artificial hibernation. Anesth. Analg. 9, 232.
17. Lickey, M., Gordon, B., 1983. Drugs for mental illness. A revolution in psychiatry. W.H. Freeman, New York.
18. López-Muñoz, F., Alamo, C., Cuenca, E., 1998. Fármacos antipsicóticos. In: López-Muñoz, F., Alamo, C. (Eds.), Historia de la Neuropsicofarmacología. Una nueva aportación a la terapéutica farmacológica de los trastornos del Sistema Nervioso Central. Ediciones Eurobook S.L. and Servicio de Publicaciones de la Universidad de Alcalá, Madrid, pp. 207-243.
19. López-Muñoz, F., Alamo, C., Cuenca, E., 2002. Aspectos históricos del descubrimiento y de la introducción clínica de la clorpromazina. Frenia. Rev. Hist. Psiquiatr. 2, 77-107.
20. López-Muñoz, F., Alamo, C., Cuenca, E., 2003. Aportación de la clorpromazina al desarrollo de la psiquiatría. Arch. Psiquiatr. 66, 15-34.
21. Pichot, P., 1996. The discovery of chlorpromazine and the place of psychopharmacology in the history of the psychiatry. In: Healy, D. (Ed.), The Psychopharmacologists. Chapman and Hall, New York, pp. 1-27.
22. Shen, W.W., Giesler, M.C., 1998. The discoverers of the therapeutic effect of chlorpromazine in psychiatry: qui étaient les vrais premiers practiciens? Can. J. Psychiatry 43, 423-424.
23. Shorter, E., 1997. A history of psychiatry. From the Era of Asylum to the Age of Prozac. Wiley, New York, p. 255.
24. Swazey, J.P., 1974. Chlorpromazine in psychiatry. A study of therapeutic innovation. MIT Press, Cambridge.